Series BBioTech
$45M
54Gene - Series B $45,000,000 raised a Series B round in October 2021
NigeriaWest AfricaInvestors
Undisclosed investors
About this deal
54gene raised $45M Series B for African genomics before closing in 2023.
Deal details
Amount$45M
StageSeries B
InstrumentEquity
SectorBioTech
RegionWest Africa
FounderMale-led
StatusClosed